Celgene Inc., established in Mississauga, ON in 2006, the Canadian affiliate of Celgene Corporation, headquartered in Summit, New Jersey, is an integrated global pharmaceutical company engaged primarily in the discovery, development and commercialization of innovative therapies for the treatment of cancer and inflammatory diseases through gene and protein regulation.

For more information, please visit www.celgene.com.